CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 193 enrolled
Drug / intervention
questionnaire administration +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00896649
NCT00896649N/ACompleted

Impact of Dedicated Breast Positron Emission Mammography vs. Conventional Two-View Digital Mammography on Recall Rates and Cancer Detection as a Screening Examination in Underserved Women

Boston Medical Center·interventional·Posted May 12, 2009·Updated May 9, 2017

In Brief

A clinical study evaluating questionnaire administration, digital mammography, and 1 other intervention for Breast Cancer. Completed, enrolled 193 participants across 1 site.

Detailed Summary

RATIONALE: Screening tests may help doctors find cancer cells early and plan better treatment for breast cancer. It is not yet known whether positron emission mammography is more effective than standard mammography in finding breast tumors. PURPOSE: This phase III trial is studying positron emission mammography to see how well it works compared with standard mammography in women undergoing screening mammogram at Boston Medical Center.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 12, 2009
Enrollment StartFeb 1, 2009
Primary CompletionJul 1, 2012
Study CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 17.1 years ago

Interventions

questionnaire administrationother

Questionnaire regarding patient satisfaction with mammogram experience and with positron emission mammography experience.

digital mammographyprocedure

standard screening mammogram

positron emission mammographyprocedure

one-time positron emission mammography to compare recall rates with that of standard mammogram